Trial of STX-100 in Patients with Idiopathic Pulmonary Fibrosis

Purpose
The purpose of this Phase II study is to evaluate the safety, tolerability, pharmacokinetics, and impact on biomarkers of STX-100 in patients with IPF. The study is enrolling patients at sites across the United States.